EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Head‐to‐head comparison of relevant cell sources of small extracellular vesicles for cardiac repair: Superiority of embryonic stem cells

Hernán González-King iD, Patricia G Rodrigues, Tamsin Albery, Benyapa Tangruksa, Ramya Gurrapu, Andreia M Silva iD, Gentian Musa, Dominika Kardasz, Kai Liu, Bengt Kull, Karin Åvall, Katarina Rydén-Markinhuhta und 14 weitere

Journal of Extracellular Vesicles · 2024-05 · 13 (5)

DOI: 10.1002/jev2.12445 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 06.05.2024. Verfasst von Hernán González-King und 25 weiteren Autor:innen. Beteiligte Einrichtung: Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Mölndal, Sweden. Hauptthemen laut MEDLINE: Extracellular Vesicles, Myocardial Infarction, Myocytes, Cardiac, Mesenchymal Stem Cells. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Högskolan i Skövde.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small extracellular vesicles (sEV) derived from various cell sources have been demonstrated to enhance cardiac function in preclinical models of myocardial infarction (MI). The aim of this study was to compare different sources of sEV for cardiac repair and determine the most effective one, which nowadays remains limited. We comprehensively assessed the efficacy of sEV obtained from human primary bone marrow mesenchymal stromal cells (BM‐MSC), human immortalized MSC (hTERT‐MSC), human embryonic stem cells (ESC), ESC‐derived cardiac progenitor cells (CPC), human ESC‐derived cardiomyocytes (CM), and human primary ventricular cardiac fibroblasts (VCF), in in vitro models of cardiac repair. ESC‐derived sEV (ESC‐sEV) exhibited the best pro‐angiogenic and anti‐fibrotic effects in vitro. Then, we evaluated the functionality of the sEV with the most promising performances in vitro, in a murine model of MI‐reperfusion injury (IRI) and analysed their RNA and protein compositions. In vivo, ESC‐sEV provided the most favourable outcome after MI by reducing adverse cardiac remodelling through down‐regulating fibrosis and increasing angiogenesis. Furthermore, transcriptomic, and proteomic characterizations of sEV derived from hTERT‐MSC, ESC, and CPC revealed factors in ESC‐sEV that potentially drove the observed functions. In conclusion, ESC‐sEV holds great promise as a cell‐free treatment for promoting cardiac repair following MI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesMyocardial InfarctionMyocytes, CardiacMesenchymal Stem CellsHumansAnimalsMiceEmbryonic Stem CellsHuman Embryonic Stem CellsFibroblastsMaleMyocardial Reperfusion InjuryDisease Models, AnimalNeovascularization, PhysiologicCells, Cultured

Stichwörter der Autor:innen

angiogenesisfibrosisimmunomodulationmyocardial ischaemia‐reperfusion injuryregenerationsmall extracellular vesicles

Autor:innen und Institutionen

  • Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Mölndal, Sweden.
  • Systems Biology Research Center, School of Bioscience, University of Skövde, Skövde, Sweden.
  • Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • AstraZeneca India Private Limited, Neville Tower 11th Floor, Ramanujan IT SEZ, Rajv Gandhi Salai (OMR), Taramani, Chennai, Tamil Nadu, India.
  • Discovery Sciences, Oligo Assay Development, BioPharmaceuticals R&D, AstraZeneca, Mölndal, Sweden.
  • Anjarium Biosciences AG, Schlieren, Switzerland.

ORCID-Profile: Hernán González-King, Andreia M Silva, Hadi Valadi

Förderung

  • Högskolan i Skövde

Zitieren

APA

González-King, H., Rodrigues, P. G., Albery, T., Tangruksa, B., Gurrapu, R., Silva, A. M., Musa, G., Kardasz, D., Liu, K., Kull, B., Åvall, K., Rydén-Markinhuhta, K., Incitti, T., Sharma, N., Graneli, C., Valadi, H., Petkevicius, K., Carracedo, M., Tejedor, S., …, & Jennbacken, K. (2024). Head‐to‐head comparison of relevant cell sources of small extracellular vesicles for cardiac repair: Superiority of embryonic stem cells. Journal of Extracellular Vesicles, 13(5). https://doi.org/10.1002/jev2.12445

Vancouver

González-King H, Rodrigues PG, Albery T, Tangruksa B, Gurrapu R, Silva AM, et al. Head‐to‐head comparison of relevant cell sources of small extracellular vesicles for cardiac repair: Superiority of embryonic stem cells. Journal of Extracellular Vesicles. 2024;13(5). doi:10.1002/jev2.12445

BibTeX
@article{GonzlezKing2024,
  author = {González-King, Hernán and Rodrigues, Patricia G and Albery, Tamsin and Tangruksa, Benyapa and Gurrapu, Ramya and Silva, Andreia M and Musa, Gentian and Kardasz, Dominika and Liu, Kai and Kull, Bengt and Åvall, Karin and Rydén-Markinhuhta, Katarina and Incitti, Tania and Sharma, Nitin and Graneli, Cecilia and Valadi, Hadi and Petkevicius, Kasparas and Carracedo, Miguel and Tejedor, Sandra and Ivanova, Alena and Heydarkhan-Hagvall, Sepideh and Menasché, Phillipe and Synnergren, Jane and Dekker, Niek and Wang, Qing-Dong and Jennbacken, Karin},
  title = {Head‐to‐head comparison of relevant cell sources of small extracellular vesicles for cardiac repair: Superiority of embryonic stem cells},
  journal = {Journal of Extracellular Vesicles},
  year = {2024},
  volume = {13},
  number = {5},
  doi = {10.1002/jev2.12445}
}
Kostenlos starten →